Sven Brunner

CEO and Founder

holo|one

Sven is founder and CEO of holo|one, a leading Mixed Reality software company. holo|one offers a standardized Mixed Reality collaboration platform targeting the high-value enterprise use cases – remote assistance, workflow guidance and live collaboration. Their solution has been adopted across the globe by Fortune 500 companies like Micron, Lenovo and the Renault Group, along with garnering several awards and accolades.

 

Before founding holo|one, Sven worked as a software engineer and product manager at Disney Research, ETH Zurich, and his own consulting firm. Sven holds a master’s degree in informatics from the University of Zurich and is a recipient of the Swiss National Bank’s Economics Award.

Sophio Tatabadze

Managing Compliance Officer, Head of Sanctions Advisory, Financial Crime Compliance

Danske Bank

Emanuella Marrone

Group Trade Controls Compliance Manager

Vodafone Group Plc

Suzanne Renes

European Patent Attorney

Sanofi

Suzanne graduated Cum Laude from Amsterdam University College in 2015 with a BSc in Biomedical Sciences. In 2016 she graduated from University College London with an MSc in Pharmaceutical Formulation and Entrepreneurship. She is a qualified Dutch and European Patent Attorney that started her career in the Pharma team at NLO in 2018. Since January 2022 she has been employed in the Ablynx team of Sanofi in Ghent, where she has been working as a patent attorney specializing in immunoglobulin single variable domains (camelid-derived VHH). In her free time, she enjoys learning new languages, playing badminton and dancing salsa.

Christoph Rehfuess

Head of IP

Sotio

Margaret O’Gara

Head of Intellectual Property

Nanobiotix

Margaret is a French and European patent attorney currently heading IP at a late development stage biotech in Paris, called Nanobiotix.

She started her professional career as a researcher in the pharma industry in the UK and France, before moving into patents in 2004.

Since then she has worked both in-house and in IP firms and spent nearly ten years with Santarelli before taking the IP position at Nanobiotix early 2020. Margaret has considerable experience in all aspects of European patent prosecution, and post grant proceedings, as well as strategies for filing new applications . She is interested in data exclusivity and prolonging the protection of innovative products.

Bea McDonald

Head of IP

Vaccitech